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Abstract 
Purpose:  
To develop an Artificial-Intelligence (AI) agent for fully automated rapid head-and-neck IMRT 
plan generation without time-consuming dose-volume-based inverse planning. 
Methods:  
This AI agent was trained via implementing a conditional Generative Adversarial Network (cGAN) 
architecture. The generator, PyraNet, is a novel Deep Learning network that implements 28 classic 
ResNet blocks in pyramid-like concatenations. The discriminator is a customized 4-layer 
DenseNet. The AI agent first generates multiple customized 2D projections at 9 template beam 
angles from a patient’s 3D CT volume and structures. These projections are then stacked as 4D 
inputs of PyraNet, from which 9 radiation fluence maps of the corresponding template beam angles 
are generated simultaneously. Finally, the predicted fluence maps are automatically post-processed 
by Gaussian deconvolution operations and imported into a commercial treatment planning system 
(TPS) for plan integrity check and visualization.  
The AI agent was built and tested upon 231 oropharyngeal IMRT plans from a TPS plan library. 
200/16/15 plans were assigned for training/validation/tests, respectively. Only the primary plans 
in the sequential boost regime were studied. All plans were normalized to 44Gy prescription 
(2Gy/fx). A customized Harr wavelet loss was adopted for fluence map comparison during the 
training of the PyraNet. For test cases, isodose distributions in AI plans and TPS plans were 
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qualitatively evaluated for overall dose distributions. Key dosimetric metrics were compared by 
Wilcoxson Signed Rank tests with a significance level of 0.05.  
Results:  
All 15 AI plans were successfully generated. Isodose gradients outside of PTV in AI plans were 
comparable with TPS plans. After PTV coverage normalization, Dmean of left parotid 
(DAI=23.1±2.4Gy; DTPS=23.1±2.0Gy), right parotid (DAI=23.8±3.0Gy; DTPS=23.9±2.3Gy), and 
oral cavity (DAI=24.7±6.0Gy; DTPS=23.9±4.3Gy) in the AI plans and the TPS plans were 
comparable without statistical significance. AI plans achieved comparable results for maximum 
dose at 0.01cc of brainstem (DAI=15.0±2.1Gy; DTPS=15.5±2.7Gy) and cord+5mm 
(DAI=27.5±2.3Gy; DTPS=25.8±1.9Gy) without clinically-relevant differences, but body Dmax 
results (DAI=121.1±3.9Gy; DTPS=109.0±0.9Gy) were higher than the TPS plan results. The AI 
agent needs ~3s for predicting fluence maps of an IMRT plan. 
Conclusions:  
With fully automated execution, the developed AI agent can generate complex head-and-neck 
IMRT plans with satisfying dosimetry quality. With rapid and fully automated implementation, it 
holds great potential for clinical applications in pre-planning decision-making and real-time 
planning.  
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1. Introduction 
Head and Neck cancer (HNC) is estimated to be account for 53260 new cases and 10750 new 
deaths in the United States in 20201. For about 40% of patients with early-stage HNC, single 
modality treatment with radiotherapy or surgical resection is usually recommended. For the rest 
about 60% of patients with advanced-stage HNC, multi-modality treatment with 
surgery/chemotherapy/radiotherapy is usually recommended2, 3. Thus, radiotherapy plays an 
irreplaceable role in HNC management as it is utilized at least once in about 80% of HNC patients4. 
In general, HNC radiotherapy planning is a challenging task. The non-convex geometrical shapes 
of irradiation targets and the typical overlaps of irradiation targets and organs-at-risk (OARs) 
require delicate radiation beam modulations for OAR sparing. Intensity modulated radiation 
therapy (IMRT) could achieve highly conformal dose distribution with decent OAR sparing 
results5. Thus, IMRT has become a standard technique for HNC in current radiation oncology 
practice6. However, the current IMRT-based HNC treatment planning remains challenging. 
Compared with IMRT planning of other anatomical sites, multiple OARs need to be evaluated and 
balanced in the time-consuming inverse planning, and more runs of inverse planning in the trial-
and-error style is required before finding an optimal plan. Thus, manual IMRT planning could be 
resource-intensive in terms of human labor and time. In addition, the overlaps of targets and 
parallel OARs make it difficult to determine the optimal dose trade-off between target coverage 
and OARs’ mean dose level. In the current manual planning process, such dose trade-off is 
determined by the initial dose-volume constraints and the possible adjustments during the inverse 
optimization, and these settings come from the planners’ previous experience and the institutional 
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practice guidelines. The variation of planners’ experience and institutional practice preferences 
may lead to considerable HNC IMRT plan quality variations7-9. As a result, automated IMRT 
planning of HNC has been of the community’s interest to enhance IMRT planning efficiency and 
potentially improve plan quality consistency10. 
In recent years, considerable efforts and progress have been made for automatic treatment planning 
to improve planning efficiency and consistency10, 11. As an early commercialized approach, 
knowledge-based planning (KBP) was designed to summarize and learn the general patterns 
between anatomy and dosimetric outcomes from previous clinical plans9, 12. The dose-volume 
histogram (DVH) predictions by the KBP model could provide guidance to human planners for 
manual inverse planning. A similar approach studies verified clinical plans to form a library 
reference; for each new case, a selected group of reference based on the designed similarity 
measures can be provided to help physicians and planners to estimate best achievable dosimetric 
quality for new cases13. As an alternative approach, multi-criterion optimization (MCO) could 
explore dosimetric tradeoffs by searching the interpolated pareto surface formed by multiple 
anchor plans that represent different dosimetric goals; the final plan of desired dosimetric tradeoffs 
can be determined by human planners after navigating the pareto surface14-17. Though 
demonstrated with clinical benefits, successful applications of these techniques still require good 
human practice during manual planning process, and the outcome plan quality may vary with 
human knowledge and preferences. In addition, these techniques rely on time-consuming inverse 
planning in their implementation, and thus efficiency improvement from information guidance to 
the human planners could be limited.  
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Recently, artificial intelligence (AI) application has become one of the trending topics in precision 
medicine10, 18. As the central topic of AI-related research, deep learning (DL) grants the 
opportunity for automated IMRT treatment planning towards real-time implementation by its 
unprecedented computation power and data modeling complexity. As one of the main research 
topics in radiation oncology, DL-based dose distribution prediction using patients’ anatomy has 
been recently reported19, 20. A few works have explored the feasibility of using dose predictions as 
guidelines of inverse planning, i.e., dose mimicking, to generate a radiotherapy plan21-23. Plan 
generation from dose distribution prediction without inverse planning has been recently reported24. 
These pioneer works used dose distribution predictions as a key intermediate step to generate a 
radiotherapy plan from patients’ anatomy. Because the dose distribution prediction comes from 
patients’ anatomy, DL-based plan generation using patients’ anatomy would be feasible with 
potentially improved efficiency.  
In this work, we propose an AI agent for fully automated HNC IMRT planning. Following the 
concept of a previous work25, using patient’s anatomy information, the proposed AI agent directly 
generates optimal radiation fluence intensity maps of an IMRT plan. No inverse planning or dose 
distribution prediction is required in this process. The generated fluence map predictions can be 
directly converted into a deliverable plan in a commercial treatment planning system (TPS). This 
AI agent requires minimum human interventions and has very high implementation efficiency.   
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2. Materials and Methods 
2.A. Patient data and processing 
In this work, 231 oropharyngeal IMRT patients were retrospectively studied under IRB approval. 
All patients were treated with the sequential boost regime, and the primary plans treating 
intermediate/low-risk PTVs were studied. These cases were randomly assigned to training (200 
cases), validation (16 cases), and independent test groups (15 cases). To address the plan 
heterogeneity due to variations of prescription, delivery technique, machine profile, and dose 
calculation algorithms, all cases were replanned in a separate research-only TPS environment 
(EclipseTM 13.6, Varian Medical System, Palo Alto, CA) using a clinically-validated in-house 
script. Based on the Eclipse Scripting Application Programming Interface (ESAPI), this script read 
the DVH results of the original clinical plan and used them as guidelines for inverse planning. 
During the inverse planning, a built-in strategy would dynamically adjust the DVH constraints 
towards convergence. Specifically, 231 IMRT plans of 44Gy in 2Gy/fx (referred to as TPS plans) 
were generated using a 9-static beam arrangement template (starting at PA direction, 40º increment) 
and 6MV beam energy on a TrueBeamTM platform. Shoulder avoidance of lateral beam entrance 
was included. Dose calculations with heterogeneity correction (AAA_13714) using a 2.5mm grid 
size were performed for all plans.  
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2.B. AI Agent Training and Implementation 
The overall workflow of the AI Agent training and implementation is summarized in Figure 1. As 
shown in Figure 1(a), the architecture of conditional Generative Adversarial Network (cGAN)26 is 
implemented in this DL network, where the generator (PyraNet) and the discriminator (DenseNet) 
were simultaneously trained in the training workflow. The generator generates a set of 9 raw 
fluence maps as the IMRT plan parameters using a 4D input, which is engineered to represent a 
patient’s volumetric anatomy information. The discriminator evaluates if a set of fluence maps is 
‘true’ (ground truths from a TPS plan) or ‘false’ (outputs from the generator) under the condition 
of the same 4D input. In each training epoch, the discriminator was trained to distinguish the 
generator’s outputs (‘false’) from the ground truths (‘true’), and the generator was trained to 
generate outputs that were similar to the ground truths with maximized ‘true’ results feedback from 
the discriminator. A Harr wavelet27 loss function was selected to evaluate the differences between 
the output raw fluence maps and the ground truths for the generator’s training, and the mean 
squared error (MSE) was used to model the binarized classification results for the discriminator’s 
training. The cGAN training was completed after 600 epochs. Figure 1(b) shows the 
implementation of the AI agent to generate an IMRT plan of a test patient. After generating 4D 
input from a patient’s anatomy, the trained generator would generate a set of 9 raw fluence maps 
for an IMRT plan, which would be subsequently processed as final output fluence map results. 
Finally, an IMRT plan would be finalized in the TPS (Eclipse) using the final output fluence maps 
as parameters. 
 
10 
 
 
 
 
Figure 1. The overall workflows of this study. (a) the training workflow. (b) the test/implementation workflow.  
 
It is important to model a patients’ anatomy information in a certain format as effective inputs of 
DL execution. Given the geometrical configurations of common oropharyngeal IMRT patients, 
two types of 2D projections were carefully engineered to summarize a patient’s anatomical 
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features at each static beam angle: 1) intra-structure projection, which is the photon attenuation 
coefficient integration within the 3D volume of a selected structure; and 2) interface projections, 
which is defined as the photon attenuation coefficient integration between the radiation entrance 
interface at body and radiation exit interface of a selected structure25, 28, 29. In this work, intra-
structure projections of the PTV and the CTV as well as interface projections of PTV, CTV, and 
8 OARs (brainstem, cord+5mm, left/right parotids, oral cavity, larynx, pharynx, and mandible) 
were included as 12 channels at each beam angle. The in-plane resolution of the projections was 
2.5mm. Thus, a total of 12×9 = 108 projections were generated and were stacked as a 4D input of 
the generator. The 4 dimensions are projection rows (128), projection columns (128), beam angles 
(9), and projection channels (12). 
In the designed cGAN architecture, the generator is a novel DL network, PyraNet. As illustrated 
in Figure 2(a), 28 ResNet30 blocks are concatenated in a pyramid-like shape to form an end-to-end 
relationship between input and output. Each ResNet block is represented by Rn, which contains 
three cascaded 3D convolutional layers. The 1st and 3rd layers are summed as the outcome of this 
ResNet block. The 3 dimensions of the filters in the 3D convolutional layers interact with 2D 
projection rows, 2D projection columns, and beam angles respectively in the 4D input. The Rn×m 
in each rounded rectangle represents m cascaded ResNet block with a base feature number of n in 
the convolutional layers. The rounded rectangles are color-coded with the filter sizes in the 3D 
convolutional layers. When the filter size is larger than (3×3×1), the layer is cyclically padded 
along the dimension of beam angles before the following convolution layers in the first ResNet 
block in each rounded rectangle. Figure 2(b) explains the cyclical padding operation. Such design 
enables information sharing among different beam angles to render volumetric information. All 
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convolution layers are followed by an exponential linear unit (ELU) activation layer. The output 
of the generator is a 128×128×9 matrix, which contains 9 raw fluence maps (in-plane resolution 
2.5mm) of 9 beams in an IMRT plan.   
Figure 2. Network structure diagram. (a) Generator: PyraNet. Layers are color-coded by different filter sizes. (b) Illustration of 
cyclic padding for filter size 3×3×5. (c) Discriminator: customized DenseNet. a: Atrous rate in the convolutional layer. Cat: 
concatenation. Conv: convolution. Sigmoid: sigmoid activation.  
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Figure 2(c) shows the discriminator of the cGAN, which is a customized 4-layer DenseNet31. The 
fluence maps (‘True’ or ‘False’) in 128×128×9 dimension are attached to the 4D input 
(128×128×9×12) to form a concatenated input (128×128×9×13) of the discriminator. This input is 
processed by 4 different convolution operations with different Atrous rates, and the resultant 4 
intermediate layers are then concatenated for subsequent operations. All except last one 
convolutional layers are followed by an ELU activation layer before the last convolution layer. A 
sigmoid layer is used to activate the last convolution layer; thus, the output 4D matrix 
(128×128×9×256) has element values between 0 and 1: all 1-value result represents ‘absolute true’, 
and all 0-value result represents ‘absolute false’. 
In each epoch during the cGAN training, discriminator was updated by an Adam optimizer with a 
learning rate of 2e-4, and the combined model (i.e., generator + discriminator) was updated by 
another Adam optimizer with a learning rate of 2e-5 while the discriminator parameters were 
temporarily locked. The combined model’s loss function was the sum of the generator’s loss (Harr 
Wavelet loss in Figure 1(a)) and 200 times the discriminator’s loss (MSE in Figure 1(a)). The 
batch size was 5 in each epoch. The generator from the epoch with minimum average Harr Wavelet 
loss in the validation group was selected to build the proposed AI agent. 
As indicated in Figure 1(b), when implementing the AI agent for a new patient, the raw output 
fluence maps from the generator need to be post-processed independently form the DL section. 
Specifically, the raw output fluence maps are processed by two Gaussian deconvolutions with 
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fixed kernel sizes (15×2.5mm/9×2.5mm), respectively. As the last part of the holistic workflow, 
the final output fluence maps would be automatically transferred to the aforementioned research 
TPS by a script for finalization. This script creates an empty plan and attaches the final output 
fluence maps to the template static beams as the optimal fluence maps. A plan would be available 
after MLC leaf motion sequence calculation (Smart LMC algorithm). In addition, dose calculation 
and DVH estimations are also included and are executed in the same way as in TPS plan generation. 
2.C. Plan Evaluation 
To demonstrate the feasibility of the developed AI agent, 15 plans (referred to as AI plans in the 
following text) were generated by the developed AI agent using the independent test patient cohort. 
The AI plans were first evaluated by experienced board-certified medical physicists as initial 
quality checks. Isodose distributions were qualitatively evaluated. Subsequently, key dosimetric 
parameters that are used in our clinic for oropharyngeal plan evaluation were compared with the 
TPS plans. Statistics were analyzed by Wilcoxon Signed Rank tests with a significance level of 
0.05.  
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3. Results 
Figure 3 shows the dose distribution comparison between the TPS plan and the AI plan of a test 
patient. After plan normalization (95% coverage to PTV with skin cropping), the PTV (orange 
segment) has comparable dose coverage by the 100% isodose lines in the axial view and coronal 
view in both plans. The coverage conformity results are about the same with some minor visual 
differences. In addition, the overall dose falloff patterns outside of PTV in these two plans share 
common geometric patterns. The OAR sparing in the AI plan are comparable with the TPS plan. 
In the 1st row of Figure 3, the 50% isodose line (orange) forms cold spots in the triangular fashion 
around the larynx (cyan contour) as effective larynx sparing. Cord sparing (dark blue contour, 50% 
isodose line) is also observed in both plans. In the 2nd row of Figure 3, right parotid (lime contour) 
sparing can be appreciated by the 50% isodose line and left parotid (green contour) sparing can be 
appreciated with even lower 30% isodose line (lime) with concaved shape, achieved by AI-plan in 
high resemblance of human plan. The coronal view in Figure 3 also demonstrates similar dose 
falloffs on the superior-inferior direction.  
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Figure 3. Dose distribution comparison between the TPS plan (left) and the AI plan (right) of a test patient. Orange contour: PTV. 
Lime contour: right parotid. Green contour: left parotid. Cyan contour: larynx. Blue contour: pharynx. Yellow contour: oral cavity. 
Overlapped blue & yellow contour: cord+5mm. 
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Figure 4 shows the optimal fluence map comparison between the TPS plan and the AI plan in the 
BEVs of 3 beam angles of the same test patient in Figure 3. In general, AI plan fluence maps have 
similar intensity ranges as in TPS plans and preserve most morphological features. As examples, 
the yellow arrows show elevated intensity at superior rims of 180º beam (PA) in both plans for 
intended target coverage improvement. In 20º beam results (LAO), both plans show an elevated 
intensity region (red arrows) with sharp gradients for potential larynx sparing. The TPS plan 
fluence maps have more choppy patterns within the low-gradient regions as high-frequency 
components; in contrast, the AI plan fluence maps are generally smoother in the low gradient 
regions, though the overall low-frequency layouts are captured.  These results indicate that the 
developed AI agent acquired effective knowledge of interpreting the implicit and sophisticated 
relationship between patient anatomy and fluence maps. 
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Figure 4. Fluence map comparison of the test patient at 3 beam angles.   
 
Figure 5 shows the boxplots of the OAR dosimetric parameters’ comparisons of all 15 test patients. 
Detailed numerical results are listed in Table 1. In general, most OAR dose-volume parameter 
results in the AI plans were comparable with the TPS plan results without significant difference. 
Cord+5mm max dose results (D0.1cc) in AI plans were slightly higher than TPS plans. Though 
larynx mean dose results in AI plans were significantly lower than TPS results, the small 
improvements do not have clinically relevant differences. 3D body max dose results (D2cc) of AI 
plans were higher than TPS plans, though all hotspots were verified within the CTV volumes. In 
addition, the total MU in the TPS plans and the AI plans is 1917.5±203.7 and 1771.3±206.5, 
respectively. These results suggest that the dosimetric qualities made by the designed AI are 
acceptable in reference to the current clinical practice.  
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Figure 5. Boxplot comparisons of dosimetric results in the independent test group (15 test patients). 
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Table 1. Numeric dosimetric results in the independent test group (15 test patients). All results were reported in the form of mean 
± standard deviation.  
 TPS plans AI plans p 
BODY D2cc (%) 109.0±0.9 121.1±3.9 <0.01* 
Brainstem D0.1cc (Gy) 15.5±2.7 15.0±2.1 0.39 
Cord+5mm D0.1cc (Gy) 25.8±1.9 27.5±2.3 <0.01* 
Left Parotid Dmean (Gy) 23.1±2.0 23.1±2.4 0.85 
Left Parotid V30% (%) 64.3±6.9 64.5±9.1 0.98 
Right Parotid Dmean (Gy) 23.9±2.3 23.8±3.0 0.68 
Right Parotid V30% (%) 68.6±11.1 68.7±10.9 0.52 
Oral Cavity Dmean (Gy) 23.9±4.3 24.7±6.0 0.23 
Larynx Dmean (Gy) 22.7±4.8 21.8±5.6 0.03* 
Pharynx Dmean (Gy) 34.7±2.5 35.1±2.8 0.23 
 
The DL training was performed on a workstation with 36 Intel® Xeon® W-2195 CPUs (2.3GHz, 
256GB RAM in total) and 4 NVIDIA Quadro RTX 8000 GPUs (48GB dedicated memory each). 
The overall training time of 600 epochs was about 78 hours. The implementation of the developed 
AI agent for new plan generation was performed on a workstation with an Intel® Xeon® E5-2640 
v4 (2.4GHz, 64GB RAM) and an NVIDIA Quadro M4000 GPU (8GB dedicated memory). On 
average, the AI agent took less than 1min for patient data processing, including CT image loading, 
structure contour reconstruction, and 2D projection generation. The generator took ~2s per patient 
for fluence map prediction on GPU, and the post-processing of fluence maps required ~1s per 
patient on CPU. This is a significant improvement from current inverse planning practice that may 
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take 30 minutes or more. Operations in the TPS that includes MLC leaf motion sequence 
calculation and 3D dose calculation took less than 1min per patient. Thus, the execution of the AI 
agent for new IMRT plan generation may take up to 2-3 mins in a fully automated way.   
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4. Discussion 
To our best knowledge, the proposed AI agent is the first of its kind that realized direct optimal 
fluence map generation from patient anatomy for head-and-neck-cancer patients. This AI agent 
does not invoke the inverse planning algorithm or process, and no human operation is required 
when predicting new cases. The AI agent studied in this project has three key innovations. First, 
the AI agent employs two types of 2D projections as highly efficient representations of a patient’s 
anatomy information. A sufficient amount of volumetric information was captured by these 
engineered 2D projections, which led to the successful dosimetric results; at the same time, such 
2D projection reduced a patient’s data size (from 3D CT/structure volumes) by more than 200 
times. In addition, the 2D projection generation could be further accelerated by parallel computing 
and hardware upgrades. The second innovation is the use of cGAN architecture. Implied by its 
name, cGAN is designed to generate non-existing images under certain conditions32. In clinical 
practice, the relationship between radiation fluence maps and dosimetric results is not injective: 
different groups of radiation fluence maps may lead to the same or very similar volumetric dose 
distribution. The adversarial logic would be suitable to determine the nonunique solution of the 
radiation fluence maps with the learning evaluation criteria. The generator in the cGAN, PyraNet, 
was a compounding DL network based on the ResNet block concatenation. The introduction of 
the discriminator may assist the PyraNet’s learning of subtle features of radiation fluence maps 
that may not be fully modeled by the Harr Wavelet loss function. The third innovation is the 
potential integration with the current commercial TPS. The training cases came from a TPS, and 
the modeled plan parameters, i.e., radiation fluence maps, are in a format accepted by the TPS. As 
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a result, the DL results would be able to be presented in a commercial TPS for easier evaluations 
against current practice. Based on the ESAPI function, the execution of the trained AI agent would 
be feasible to be within the TPS environment without massive data transfer. In comparison with 
other feasibility studies of DL-based IMRT planning, our work would be a step ahead towards 
validation and potential application in the clinic.    
Recently, DL-based spatial dose distribution prediction has been reported by many works within 
the radiation oncology society. Indeed, a predicted dose distribution would assist physicians and 
planners’ decision-making process prior to the actual planning task. However, it remains unclear 
how to utilize the predicted dose distribution to automatically generate a deliverable IMRT plan 
without manual operations. A pilot work have demonstrated the feasibility of DL-based radiation 
fluence map prediction using patient anatomy and dose distribution prediction in prostate IMRT 
application; however, the actual planned dose distribution was used as dose distribution prediction 
surrogates24. Our results demonstrated the feasibility of DL-based radiation fluence map prediction 
using patient anatomy only for head-and-neck-cancer IMRT. In addition, the proposed AI agent 
avoided the potential error propagation from the dose distribution prediction results to the 
generated IMRT plan. Nevertheless, conclusions might not be drawn at this early stage since few 
works has reported radiation fluence map prediction using dose prediction for HNC IMRT 
planning. In future works, it would be of interests to investigate if DL-based HNC IMRT plan 
generation could be benefited from dose distribution prediction inclusion in input design. 
One limitation of the current work is the 3D maximum dose results. D2cc of BODY in AI plans 
was higher than TPS plan results and was about 20% higher than the prescribed dose level, though 
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all hotspots were found in CTV. The hotpot positions may vary daily in a regular fractionation 
regime, and the received high dose irradiation may be spatially averaged instead of being 
concentrated in a small region. Nevertheless, homogeneous target irradiation is favored. One 
possible reason for the current max dose results is the lack of anatomy modeling within the 
PTV/CTV. Compared to the typical cross-section size of an adult’s head, the primary target size 
of oropharyngeal IMRT is large. The designed 2 types of 2D projections intend to describe the 
complex PTV-OAR geometry; the anatomy modeling of body tissue within the target regions, 
however, may not be optimal. This may lead to the loss of high-frequency components of the 
radiation fluence map results at the core regions in the target, and the max dose results would be 
high after target coverage normalization. Future works that explore novel 2D projection recipes 
may improve the max dose results. Another limitation of the current work is the adoption of the 
fixed 9 beam arrangement template. While static beam IMRT delivery remains important, VMAT 
delivery has become more popular for oropharyngeal radiotherapy with its rapid delivery. As our 
ongoing research efforts, DL-based VMAT plan parameter prediction for simultaneous integrated 
boost (SIB) treatment of oropharyngeal radiotherapy would be a promising work towards clinical 
popularity.  
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5. Conclusion 
In this work, an AI agent was successfully developed as a DL approach for oropharyngeal IMRT 
planning. Without time-consuming inverse planning, this AI agent could automatically generate 
an oropharyngeal IMRT plan for the primary target with acceptable plan quality. With its high 
implementation efficiency, the developed AI agent holds great potentials for clinical application 
after future development validation studies.   
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